Rhinitus/Sinusitis/Ocular Allergy News

HOUSTON — Xolair signicantly improved nasal congestion and nasal polyp scores in patients with corticosteroid-refractory nasal polyps, according to data from two phase 3 trials presented at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting.

The FDA approved Dupixent for use with other medicines to treat patients with chronic rhinosinusitis with nasal polyps, the agency, Regeneron Pharmaceuticals and Sanofi all announced today.

Numerous studies have implicated Staphylococcus aureus in the development of eczema.

Children in California who were exposed to wildfire smoke had increases in asthma exacerbations, including wheezing in those who did not have asthma before the fire, compared with children exposed to smoke from prescribed burns.

A unique inflammatory signature among older patients with chronic rhinosinusitis may make them less responsive to steroid treatment, according to findings recently published in the Journal of Allergy and Clinical Immunology.

A simulation that used serology to screen children with asthma for mite sensitization saved more than $4 billion over 5 years, according to a poster presented at the American Academy of Allergy, Asthma and Immunology Annual Scientific Meeting.

Patients with severe chronic rhinosinusitis with nasal polyps treated with Dupixent showed improvements in nasal polyp size, nasal congestion severity, chronic sinus disease, sense of smell and comorbid asthma outcomes, according to data presented at the American Academy of Allergy, Asthma and Immunology Annual Scientific Meeting.

Young children with peanut allergy who received 12 months of treatment with a peanut patch had a significant difference in treatment response rate vs. those who received placebo, according to findings published in JAMA. However, the trial did not meet a prespecified criterion for a positive trial result.

There are a number of misconceptions about food allergy, and primary care physicians can best serve their patients by dispelling those inaccuracies, experts told Healio Primary Care Today.

Upper respiratory infections, or URIs, are more common among children who develop acute sinusitis, according to research published in Clinical Infectious Diseases. Although respiratory syncytial virus was the most common cause of URI among children with sinusitis, 30% of patients with the condition had a new viral pathogen present in samples collected on the 10th day of symptoms, researchers said.